Max Healthcare reports strong Q2, half-year financials with revenue, profit growth

Max Healthcare Institute Limited reported a substantial increase in its consolidated financial results for the quarter ended September 30, 2025. Revenue from operations rose to INR 2,13,547 lakhs, up from INR 1,70,746 lakhs in the same quarter last year. Consolidated profit after tax also saw a significant jump to INR 49,130 lakhs, compared to INR 28,181 lakhs in the prior year's quarter. For the half-year ended September 30, 2025, consolidated revenue reached INR 4,16,304 lakhs, with profit after tax at INR 79,927 lakhs.

Standalone results also showed positive trends, with revenue from operations for the quarter at INR 73,662 lakhs and profit after tax at INR 16,042 lakhs. The company's merger of Crosslay Remedies Limited (CRL) and Jaypee Healthcare Limited (JHL) was approved by the NCLT on November 7, 2025, effective October 5, 2024, contributing to a reversal of current tax and recognition of net deferred tax credit of INR 7,899 lakhs for the quarter.

JHL divested hospitals in Chitta and Anoopshahr for a total consideration of INR 4,066 lakhs. Shareholders approved a final dividend of INR 1.5 per share for the fiscal year ended March 31, 2025, which was subsequently paid on August 18, 2025.